↓ Skip to main content

Prenatal Stress and Maternal Immune Dysregulation in Autism Spectrum Disorders: Potential Points for Intervention.

Overview of attention for article published in Current Pharmaceutical Design, January 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)
  • High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

twitter
28 X users

Citations

dimensions_citation
30 Dimensions

Readers on

mendeley
79 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Prenatal Stress and Maternal Immune Dysregulation in Autism Spectrum Disorders: Potential Points for Intervention.
Published in
Current Pharmaceutical Design, January 2019
DOI 10.2174/1381612825666191119093335
Pubmed ID
Authors

David Q. Beversdorf, Hanna E. Stevens, Kara Gross Margolis, Judy Van de Water

X Demographics

X Demographics

The data shown below were collected from the profiles of 28 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 79 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 79 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 13 16%
Researcher 7 9%
Student > Master 7 9%
Student > Bachelor 6 8%
Student > Doctoral Student 6 8%
Other 11 14%
Unknown 29 37%
Readers by discipline Count As %
Medicine and Dentistry 12 15%
Psychology 11 14%
Neuroscience 8 10%
Biochemistry, Genetics and Molecular Biology 4 5%
Nursing and Health Professions 3 4%
Other 9 11%
Unknown 32 41%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 16. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 September 2023.
All research outputs
#2,282,460
of 25,761,363 outputs
Outputs from Current Pharmaceutical Design
#210
of 3,725 outputs
Outputs of similar age
#50,948
of 449,339 outputs
Outputs of similar age from Current Pharmaceutical Design
#7
of 163 outputs
Altmetric has tracked 25,761,363 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,725 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.0. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 449,339 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 163 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.